ArticlePloS one2016

Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway.

Zhen-Hua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.